Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2007 May;34(5):1188-93.

Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders

Florence Tubach  1 , Philippe Ravaud, Dorcas Beaton, Maarten Boers, Claire Bombardier, David T Felson, Desireé van der Heijde, George Wells, Maxime Dougados
Affiliations
Multicenter Study

Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders

Florence Tubach et al. J Rheumatol. 2007 May.

Abstract

The concepts of minimal clinically important improvement (MCII) and patient acceptable symptomatic state (PASS) could help in interpreting results of trials involving patient-reported outcomes by translating the response at the group level (change in mean scores) into more clinically meaningful information by addressing the patient level as "therapeutic success (yes/no)." The aims of the special interest group (SIG) at OMERACT 8 were to discuss specific issues concerning the MCII and PASS concepts, especially the wording of the external anchor questions used to determine the MCII and PASS estimates, and to move toward a consensus for the cutoff values to use as the MCII and PASS in the different outcome criteria. The purpose of this SIG at OMERACT 8 was to inform participants of the MCII and PASS concepts and to agree on MCII and PASS values for pain, patient global assessment, and functional impairment.

PubMed Disclaimer

References

    1. Fairclough DL. Patient reported outcomes as endpoints in medical research. Stat Methods Med Res. 2004;13(2):115–38. - PubMed
    1. Willke R, Burke B, Erickson P. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. Control Clin Trials. 2004;25(6):535–552. - PubMed
    1. Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995;38(6):727–35. - PubMed
    1. Beaton DE, Boers M, Wells GA. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheumatol. 2002;14(2):109–14. - PubMed
    1. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407–15. - PubMed

Publication types

LinkOut - more resources